# Brandywine Realty Trust: financial statements, quarterly

BDN · NYSE · CIK 790816 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bdn.md) · [Financials](/companies/bdn/financials.md) · [Filings](/companies/bdn/filings.md) · [Insiders](/companies/bdn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bdn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [130 d](/filings/0000790816-26-000008.md) | [126](/filings/0000790816-25-000020.md) | [125](/filings/0000790816-25-000034.md) | [132](/filings/0000790816-25-000046.md) | [122 d](/filings/0000790816-26-000008.md) | [122](/filings/0000790816-26-000017.md) | [121](/filings/0000790816-25-000034.md) | [121](/filings/0000790816-26-000045.md) | [121 d](/filings/0000790816-26-000008.md) | [127](/filings/0000790816-26-000017.md) | not reported | [126](/filings/0000790816-26-000045.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [83.5 d](/filings/0000790816-26-000008.md) | [79.1](/filings/0000790816-25-000020.md) | [79.0](/filings/0000790816-25-000034.md) | [85.5](/filings/0000790816-25-000046.md) | [74.6 d](/filings/0000790816-26-000008.md) | [73.9](/filings/0000790816-26-000017.md) | [75.2](/filings/0000790816-25-000034.md) | [76.0](/filings/0000790816-26-000045.md) | [74.1 d](/filings/0000790816-26-000008.md) | [75.0](/filings/0000790816-26-000017.md) | not reported | [73.5](/filings/0000790816-26-000045.md) |
| Operating income | $m | [(78.9) d](/filings/0000790816-26-000008.md) | [22.9](/filings/0000790816-25-000020.md) | [19.5](/filings/0000790816-25-000034.md) | [(9.5)](/filings/0000790816-25-000046.md) | [21.9 d](/filings/0000790816-26-000008.md) | [15.2](/filings/0000790816-26-000017.md) | [(41.3)](/filings/0000790816-25-000034.md) | [25.2](/filings/0000790816-26-000045.md) | [27.6 d](/filings/0000790816-26-000008.md) | [1.5](/filings/0000790816-26-000017.md) | not reported | [47.1](/filings/0000790816-26-000045.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0 d](/filings/0000790816-26-000008.md) | [0.0](/filings/0000790816-25-000020.md) | [0.0](/filings/0000790816-25-000034.md) | [0.0](/filings/0000790816-25-000046.md) | [0.0 d](/filings/0000790816-26-000008.md) | [0.0](/filings/0000790816-26-000017.md) | [0.1](/filings/0000790816-25-000034.md) | [0.0](/filings/0000790816-26-000045.md) | [0.0 d](/filings/0000790816-26-000008.md) | [0.0](/filings/0000790816-26-000017.md) | not reported | [0.0](/filings/0000790816-26-000045.md) |
| Net income | $m | [(157) d](/filings/0000790816-26-000008.md) | [(16.4)](/filings/0000790816-25-000020.md) | [30.2](/filings/0000790816-25-000034.md) | [(165)](/filings/0000790816-25-000046.md) | [(44.5) d](/filings/0000790816-26-000008.md) | [(27.0)](/filings/0000790816-26-000017.md) | [(88.7)](/filings/0000790816-25-000034.md) | [(25.9)](/filings/0000790816-26-000045.md) | [(36.7) d](/filings/0000790816-26-000008.md) | [(48.6)](/filings/0000790816-26-000017.md) | [(31.5)](/filings/0000790816-26-000045.md) | [(22.0)](/filings/0000790816-26-000045.md) |
| Diluted EPS | $ per share | not reported | [(0.10)](/filings/0000790816-25-000020.md) | [0.17](/filings/0000790816-25-000034.md) | [(0.96)](/filings/0000790816-25-000046.md) | not reported | [(0.16)](/filings/0000790816-26-000017.md) | [(0.51)](/filings/0000790816-25-000034.md) | [(0.15)](/filings/0000790816-26-000045.md) | not reported | [(0.28)](/filings/0000790816-26-000017.md) | not reported | [(0.13)](/filings/0000790816-26-000045.md) |
| Basic EPS | $ per share | not reported | [(0.10)](/filings/0000790816-25-000020.md) | [0.17](/filings/0000790816-25-000034.md) | [(0.96)](/filings/0000790816-25-000046.md) | not reported | [(0.16)](/filings/0000790816-26-000017.md) | [(0.51)](/filings/0000790816-25-000034.md) | [(0.15)](/filings/0000790816-26-000045.md) | not reported | [(0.28)](/filings/0000790816-26-000017.md) | not reported | [(0.13)](/filings/0000790816-26-000045.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [58.3](/filings/0000790816-26-000008.md) | [43.2](/filings/0000790816-25-000020.md) | [30.4](/filings/0000790816-25-000034.md) | [36.5](/filings/0000790816-25-000046.md) | [90.2](/filings/0000790816-26-000045.md) | [29.4](/filings/0000790816-26-000017.md) | [123](/filings/0000790816-25-000034.md) | [75.5](/filings/0000790816-26-000045.md) | [32.3](/filings/0000790816-26-000045.md) | [36.2](/filings/0000790816-26-000017.md) | not reported | [313](/filings/0000790816-26-000045.md) |
| Total assets | $m | [3,732](/filings/0000790816-25-000009.md) | [3,737](/filings/0000790816-24-000022.md) | [3,754](/filings/0000790816-24-000037.md) | [3,600](/filings/0000790816-24-000050.md) | [3,492](/filings/0000790816-26-000008.md) | [3,424](/filings/0000790816-25-000020.md) | [3,394](/filings/0000790816-25-000034.md) | [3,319](/filings/0000790816-25-000046.md) | [3,586](/filings/0000790816-26-000045.md) | [3,588](/filings/0000790816-26-000017.md) | not reported | [3,277](/filings/0000790816-26-000045.md) |
| Total liabilities | $m | [2,408](/filings/0000790816-25-000009.md) | [2,445](/filings/0000790816-24-000022.md) | [2,455](/filings/0000790816-24-000037.md) | [2,495](/filings/0000790816-24-000050.md) | [2,448](/filings/0000790816-26-000008.md) | [2,424](/filings/0000790816-25-000020.md) | [2,509](/filings/0000790816-25-000034.md) | [2,472](/filings/0000790816-25-000046.md) | [2,788](/filings/0000790816-26-000045.md) | [2,849](/filings/0000790816-26-000017.md) | not reported | [2,626](/filings/0000790816-26-000045.md) |
| Long-term debt | $m | [2,139](/filings/0000790816-24-000050.md) | [2,181](/filings/0000790816-24-000022.md) | [2,242](/filings/0000790816-24-000037.md) | [2,262](/filings/0000790816-24-000050.md) | [2,213](/filings/0000790816-26-000008.md) | [2,215](/filings/0000790816-25-000020.md) | [2,312](/filings/0000790816-25-000034.md) | [2,269](/filings/0000790816-25-000046.md) | [2,557](/filings/0000790816-26-000045.md) | [2,622](/filings/0000790816-26-000017.md) | not reported | [2,410](/filings/0000790816-26-000045.md) |
| Shareholders' equity | $m | [1,317](/filings/0000790816-25-000009.md) | [1,286](/filings/0000790816-24-000022.md) | [1,293](/filings/0000790816-24-000037.md) | [1,099](/filings/0000790816-24-000050.md) | [1,039](/filings/0000790816-26-000008.md) | [994](/filings/0000790816-25-000020.md) | [880](/filings/0000790816-25-000034.md) | [842](/filings/0000790816-25-000046.md) | [793](/filings/0000790816-26-000045.md) | [734](/filings/0000790816-26-000017.md) | [696](/filings/0000790816-26-000045.md) | [647](/filings/0000790816-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [55.9 d](/filings/0000790816-24-000037.md) | [50.1 d](/filings/0000790816-24-000050.md) | [65.9 d](/filings/0000790816-26-000008.md) | [23.8](/filings/0000790816-25-000020.md) | [48.2 d](/filings/0000790816-25-000034.md) | [52.2 d](/filings/0000790816-25-000046.md) | [56.9 d](/filings/0000790816-26-000008.md) | [6.3](/filings/0000790816-26-000017.md) | [34.4 d](/filings/0000790816-25-000034.md) | [47.5 d](/filings/0000790816-26-000045.md) | [28.5 d](/filings/0000790816-26-000008.md) | [10.2](/filings/0000790816-26-000017.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000790816-26-000017.md) | not reported | not reported | not reported | [2.2](/filings/0000790816-26-000017.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [172](/filings/0000790816-23-000047.md) | [172](/filings/0000790816-24-000022.md) | [172](/filings/0000790816-24-000037.md) | [172](/filings/0000790816-24-000050.md) | [172](/filings/0000790816-25-000020.md) | [175](/filings/0000790816-25-000034.md) | [173](/filings/0000790816-25-000046.md) | [173](/filings/0000790816-26-000017.md) | [174](/filings/0000790816-25-000034.md) | [174](/filings/0000790816-26-000045.md) | [174](/filings/0000790816-26-000017.md) | [172](/filings/0000790816-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 170,045,584 at 2026-10-21, from the cover of the [10-Q filed 2026-10-29](/filings/0000790816-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 15:29 ET. No prices; not investment advice.